Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CHSCN will rise by +3.80% over the next 2 Weeks and hit $25.83 by Friday, November 24, 2023. In that time frame, CHSCN's share price is expected to range between $25.34 and $26.28.
BearishAverageBullishCHSCN shares rose +0.08% in Wednesday, December 24, 2025's trading session, rising from a previous close of $24.88 to move at $24.90. The stock demonstrated notable intraday movement (see CHSCN's key stats for a full breakdown), fluctuating between $24.80 and $24.90, a +0.40% trading range. While recent weeks have seen some volatility, CHSCN has managed to secure a -1.07% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 13.87K shares changing hands, 18.09K fewer than the previous session. This amounted to $345.41K in total market activity.
Will CHSCN Continue Its Upward Trend?
According to analyst ratings and projections for CHSCN, CHS Inc. shares are anticipated to increase by +5.23%, potentially reaching $26.27 per share by November 24, 2023. Short-term technical indicators currently suggest a neutral sentiment for CHSCN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the CHSCN stock forecast, now is a good time to buy CHSCN stock because its current trading price is -3.58% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CHSCN covering social and institutional perspectives.
CHSCN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CHSCN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 32.67% to 39.86%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 45.61%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.66%, maintains a neutral outlook for the long term. Insights into CHSCN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

